Table 2.
Characteristics of prostate cancer cases and controls included in association study
| Cases (N = 506) | Controls (N = 506) | |
|---|---|---|
| Age (mean ± SD) | 65.7 ± 8.2 | 65.6 ± 8.3 |
| Ethnicity n (%) | ||
| African-American | 89 (18) | 89 (18) |
| Caucasian | 417 (82) | 417 (82) |
| Institution n (%) | ||
| Cleveland Clinic Foundation | 407 (80) | 407 (80) |
| University Hospitals, Cleveland | 99 (20) | 99 (20) |
| Family history of prostate cancer n (%) | ||
| Yes* | 31 (6) | 7 (1) |
| No | 475 (94) | 499 (99) |
| Tumor Stage† n (%) | ||
| T1 | 305 (60) | NA |
| T2 | 145 (29) | NA |
| T3 | 30 (6) | NA |
| Gleason Score n (%) | ||
| 5 | 3 (1) | NA |
| 6 | 79 (16) | NA |
| 7 | 314 (62) | NA |
| 8 | 67 (13) | NA |
| 9 | 39 (8) | NA |
| 10 | 4 (1) | NA |
| PSA ng/ml (mean ± SD) | 14.1 ± 27.4 | 1.7 ± 1.7 |
*1st degree relatives ≥ 2 or one 1st degree and 2nd degree relatives ≥ 2.
†Numbers do not add to 100% due to missing data